Affimed Nv Stock Z Score
AFMD Stock | USD 5.34 0.01 0.19% |
Affimed | Z Score |
Affimed Z Score Analysis
Affimed NV's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
More About Z Score | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 712K | 1.6M | 1.9M | 1.8M | Depreciation And Amortization | 24K | 1.5M | 1.7M | 1.8M |
Z Score | = | Sum Of | | 5 Factors |
Current Affimed NV Z Score | -1.15 |
Most of Affimed NV's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Affimed NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
Affimed Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Affimed NV is extremely important. It helps to project a fair market value of Affimed Stock properly, considering its historical fundamentals such as Z Score. Since Affimed NV's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Affimed NV's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Affimed NV's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
In accordance with the company's disclosures, Affimed NV has a Z Score of -1.15. This is 117.04% lower than that of the Biotechnology sector and 134.43% lower than that of the Health Care industry. The z score for all United States stocks is 113.19% higher than that of the company.
Affimed Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Affimed NV's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics of similar companies.Affimed NV is currently under evaluation in z score category among related companies.
Affimed NV Institutional Holders
Institutional Holdings refers to the ownership stake in Affimed NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Affimed NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Affimed NV's value.Shares | Two Sigma Investments Llc | 2023-12-31 | 631.6 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 607.3 K | Bnp Paribas Arbitrage, Sa | 2023-12-31 | 572 K | Vestal Point Capital Lp | 2023-12-31 | 546.1 K | State Street Corporation | 2023-12-31 | 529.4 K | Intellectus Partners, Llc | 2023-12-31 | 410.4 K | Alyeska Investment Group, L.p. | 2023-09-30 | 350 K | Ubs O'connor Llc | 2023-12-31 | 254.9 K | Abrdn Plc | 2023-12-31 | 208.6 K | 683 Capital Management Llc | 2023-12-31 | 7 M | Nea Management Company, Llc | 2023-12-31 | 4.4 M |
Affimed Fundamentals
Return On Equity | -0.93 | ||||
Return On Asset | -0.4 | ||||
Operating Margin | (12.74) % | ||||
Current Valuation | (3.5 M) | ||||
Shares Outstanding | 14.93 M | ||||
Shares Owned By Insiders | 4.45 % | ||||
Shares Owned By Institutions | 36.57 % | ||||
Number Of Shares Shorted | 171.63 K | ||||
Price To Earning | (2.04) X | ||||
Price To Book | 0.96 X | ||||
Price To Sales | 3.85 X | ||||
Revenue | 19.02 M | ||||
Gross Profit | 42.87 M | ||||
EBITDA | (113.9 M) | ||||
Net Income | (119.17 M) | ||||
Cash And Equivalents | 237.23 M | ||||
Cash Per Share | 1.59 X | ||||
Total Debt | 18.19 M | ||||
Debt To Equity | 0.1 % | ||||
Current Ratio | 4.90 X | ||||
Book Value Per Share | 5.12 X | ||||
Cash Flow From Operations | (115.79 M) | ||||
Short Ratio | 2.68 X | ||||
Earnings Per Share | (8.58) X | ||||
Target Price | 43.68 | ||||
Number Of Employees | 219 | ||||
Beta | 2.07 | ||||
Market Capitalization | 80.94 M | ||||
Total Asset | 200.51 M | ||||
Retained Earnings | (430.19 M) | ||||
Working Capital | 161.42 M | ||||
Current Asset | 78.33 M | ||||
Current Liabilities | 8.94 M | ||||
Z Score | -1.15 | ||||
Net Asset | 200.51 M |
About Affimed NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Affimed NV in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Affimed NV's short interest history, or implied volatility extrapolated from Affimed NV options trading.
Pair Trading with Affimed NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Affimed NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Affimed NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Affimed NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Affimed NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Affimed NV to buy it.
The correlation of Affimed NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Affimed NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Affimed NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Affimed NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Affimed NV Piotroski F Score and Affimed NV Valuation analysis. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Affimed NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.58) | Revenue Per Share 1.407 | Quarterly Revenue Growth (0.87) | Return On Assets (0.40) | Return On Equity (0.93) |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.